tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 166 are a BUY (82.59%), 35 are a HOLD (17.41%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 27.71% that have a potential upside of 51.72% achieved within 84 days.
Emily Bodnar’s has documented 382 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SANA, Sana Biotechnology at 24-Apr-2025.
Analyst best performing recommendations are on BCTX (BRIACELL THERAPEUTICS CORP).
The best stock recommendation documented was for NVCR (NOVOCURE LTD) at 11/21/2024. The price target of $30 was fulfilled within 12 days with a profit of $12.91 (75.54%) receiving and performance score of 62.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$48
$0.45 (0.95%)
$48
1 years 8 months 17 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
$56
1 years 10 months ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$68
1 years 10 months 6 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$38
1 years 10 months 6 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
1 years 10 months 6 days ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
